This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Acrodermatitis enteropathica

Authoring team

Acrodermatitis enteropathica (AE) is a disorder of zinc absorption.

  • occurs in two forms: an autosomal recessive inherited form and an acquired form
  • congenital form of AE is a rare genetic disorder characterized by an inborn defect in the gastrointestinal absorption of zinc
    • typically presents when the affected infant is weaned from breast feeding
  • acquired form
    • due to nutritional zinc deficiency, e.g. in premature infants who receive prolonged parenteral alimentation

Features:

  • irritability and emotional disturbances are evident in the acute due to atrophy of the brain cortex
  • skin lesions include a periorificial and acral vesiculobullous eruption leading to scaley, sharply demarcated crusted plaques

AE may be fatal without appropriate therapy; the management of this condition is with zinc supplements, either in the diet or added to total parenteral nutrition.

Click here for example images of this condition


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.